Rapid downregulation of the antiapoptotic Bcl-2 family protein myeloid cell leukemia 1 (Mcl-1) is required for UV-induced apoptosis, underlining an important role for Mcl-1 in epidermal pathology. To determine if Mcl-1 has a specific role in normal keratinocyte (KC) biology, Mcl-1 was downregulated in human KCs by RNAi and these KCs were induced to differentiate in organotypic raft cultures. Mcl-1 shRNA organotypic cultures showed increased levels of spontaneous premature apoptosis, implicating Mcl-1 as an essential KC survival protein.
INTRODUCTION
Homeostasis in the skin is maintained by a balance between two processes: cell proliferation of basal keratinocytes (KCs) and terminal differentiation of suprabasal KCs. Differentiation involves irreversible exit of KCs from the cell cycle and transit through the suprabasal spinous, granular, and ultimately cornified layers of the epidermis. It is essential for KCs to survive during the differentiation processes to carry out their barrier and systemic functions before ultimately dying by cornification. It is also essential for KCs to be able to rapidly respond to genotoxic stresses, most notably UV radiation from the sun, to eliminate damaged KCs that may be at risk of malignant transformation. The important tumor suppressor function of UV-induced apoptosis is illustrated by the increased cancer incidence in transgenic mice overexpressing cell survival proteins (Nischt et al., 1988; Pena et al., 1998) . Thus, epidermal KCs have a need for both constitutive (that is, terminal differentiation) and inducible (that is, apoptosis) cell-death pathways. Although much is known about the control of KC differentiation marker expression in viable cells, the regulatory determinants of the terminal cornification process are complex and poorly understood (Nickoloff et al., 2002; Candi et al., 2005; Lippens et al., 2005) . The KC apoptotic machinery and response to UV radiation has been extensively studied, and consists of both intrinsic/mitochondrial and receptor-mediated cell-death pathways (Ziegler et al., 1994; Schwarz et al., 1995; Rehemtulla et al., 1997; Aragane et al., 1998; Sheikh et al., 1998; Sitailo et al., 2002) . Critical mediators of UV apoptosis include activation of p53, downregulation of the antiapoptotic myeloid cell leukemia 1 (Mcl-1) protein, release of cytochrome c, and subsequent activation of a caspase cascade effecting the apoptotic elimination of damaged KCs (Sitailo et al., 2002; Nijhawan et al., 2003; Chaturvedi et al., 2005) .
The transition of KCs from the granular to cornified layer during differentiation resembles a special form of apoptosis in some aspects (Polakowska et al., 1994; Lippens et al., 2005) . The process is clearly genetically preprogrammed, and KCs become enucleated, lose all organelles, shrink, and die without inducing an inflammatory response. Several studies have examined the relationship between KC terminal differentiation and classical apoptosis, however few common features have been identified (Mitra et al., 1997; Gandarillas et al., 1999; Lippens et al., 2000) . Although classical apoptotic caspases (caspase-3, -8, -9) are not activated during KC terminal differentiation, the squamous differentiation-associated caspase-14 is selectively activated in differentiating KCs, and is involved in the terminal differ-entiation process (Lippens et al., 2000; Chien et al., 2002; Raymond et al., 2007) . The mechanism of caspase-14 activation during differentiation is unclear as this caspase is not activated by either genotoxic or death receptor apoptotic agents (Lippens et al., 2000) .
The Mcl-1 protein was initially discovered in ML-1 human myeloblastic leukemia cells after initiating differentiation of these cells by the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (Kozopas et al., 1993) . Mcl-1 is an antiapoptotic member of the Bcl-2 family of proteins involved in preserving outer mitochondrial membrane integrity by sequestering the proapoptotic Bcl-2 proteins Bak and Bax, although the binding to these proapoptotic proteins can be disrupted by BH3-only family members (that is, tBid, Puma, Noxa, Bmf, Bim) (Zhou et al., 1997; Gomez-Bougie et al., 2005; Kuwana et al., 2005; Willis et al., 2005; Clohessy et al., 2006) . Unique features of Mcl-1 include its dynamic regulation at multiple levels, and its rapid response to a wide variety of proapoptotic stimuli and growth factors (Iglesias-Serret et al., 2003; Michels et al., 2005) . For example, Mcl-1 is rapidly downregulated following UV irradiation, and this is required for cytochrome c release and apoptosis (Nijhawan et al., 2003; Sitailo et al., 2006) . Both Mcl-1 null and Bcl-x null mice die in utero (Motoyama et al., 1995; Rinkenberger et al., 2000) , although Mcl-1 null mice die much earlier (E4.0 vs E13, respectively) indicating that these antiapoptotic proteins have functions not compensated by other proteins. Of interest, the very early lethality observed in Mcl-1 null mice was associated with delayed development and not increased apoptosis, whereas the Bcl-x null embryos exhibited widespread spontaneous apoptosis. These studies, together with its initial identification as a differentiation-associated gene, suggest that Mcl-1 has additional functions in development and/or differentiation that are not shared by other Bcl-2 family members (Kozopas et al., 1993; Rinkenberger et al., 2000) . We addressed two basic questions in this paper: what is the role of Mcl-1 protein in the survival of human KCs in the context of epidermal differentiation, and does the loss of Mcl-1 influence the KC differentiation process.
RESULTS

Mcl-1 protein is localized throughout the normal human epidermis
To evaluate the role of Mcl-1 in skin biology we performed immunohistochemical staining for Mcl-1 in formalin-fixed skin tissue (Figure 1a-d) . We found that Mcl-1 was highly expressed throughout the adult human epidermis, with stronger staining in the suprabasal compartment. The antibody staining was specific as it could be prevented by preincubation with Mcl-1-blocking peptide. Western blot analysis of protein extracted from foreskin or KCs growing in culture identified Mcl-1 as 42/40 kDa protein doublet, corresponding to the antiapoptotic Mcl-1L, although one KC culture sample also contained a prominent 32 kDa Mcl-1 band. Bcl-x L was also readily detected at 33 kDa by western blot in all samples (Figure 1e ).
Altered epidermal morphology in organotypic cultures with downregulated Mcl-1
To determine the role of Mcl-1 in KC survival, we infected normal human KCs with a retrovirus encoding a specific shRNA targeting Mcl-1 , plated the cells on a collagen-fibroblast matrix, and lifted them to the air-liquid interface to generate organotypic raft cultures. As shown in Figure 2a , the Mcl-1 shRNA retrovirus reduced Mcl-1 protein levels to B45% of control in organotypic raft cultures. Hematoxylin and eosin staining of sections revealed striking differences in histology of Mcl-1 shRNA cultures compared to control (Figure 2b ). Control shRNA organotypic cultures had a well-developed histological appearance with clearly visible spinous, granular and cornified layers. In contrast, the granular layer in Mcl-1 shRNA raft was largely absent and poorly developed, and the cornified layer was Figure 4a ). Activation of caspase-3 was detected throughout the Mcl-1 shRNA epidermis with highest level detected in the upper spinous layers. Western blot analysis for full-length caspase-3 also confirmed increased proteolytic activation of caspase-3 in Mcl-1-downregulated organotypic cultures compared to control ( Figure 4b ).
Inhibition of caspase-dependent apoptosis promotes cornification
To determine if the increased spontaneous apoptosis in the spinous layer of Mcl-1 shRNA organotypic cultures was responsible for decreased histological differentiation and/or cornification, we established organotypic raft cultures in the presence of z-VAD. Histological analysis of these organotypic cultures revealed increased cornified layers in z-VAD- Figure 5a ). To quantify cornification, we trypsinized the epidermis of organotypic cultures and determined the percent of cornified envelopes produced. Figure 5b shows that Mcl-1 shRNA cultures had fewer cornified envelopes than control shRNA cultures, and that z-VAD treatment increased cornified envelope formation in both control and Mcl-1-downregulated cultures, consistent with the morphological assessment in Figure 5a . As an alternative system for differentiation induction, we used suspension culture in methylcellulose and assayed cross-linked protein formation . Figure 5c demonstrates a large induction of cross-linked protein induced by suspension culture and a reduction in protein cross-linking in the Mcl-1 shRNA cultures, although this was not a statistically significant decrease. Addition of z-VAD to the Mcl-1 shRNA suspension cultures significantly (Po0.005) increased the production of cross-linked protein ( Figure 5c ). On the basis of ability of z-VAD to inhibit caspase-dependent apoptosis and increase cornification, we conclude that the reduced cornification in Mcl-1 shRNA KCs is in part due to increased apoptosis. (Figure 7) . A similar alteration in caspase-14 expression and reduction in K10 was observed in organotypic cultures from KCs transfected with Mcl-1 siRNA oligonucleotides ( Figure S1 ). To determine if the decreased KC differentiation marker expression in Mcl-1 downregulated organotypic cultures was due to elevated apoptosis, differentiation markers were examined in cultures air-lifted in the presence of z-VAD, which inhibits spontaneous apoptosis in Mcl-1 shRNA cultures (Figure 3 ). Western blot analysis (Figure 8 ) confirmed reduced expression of loricrin, filaggrin, involucrin, K1 and K10, and lack of proteolytic processing (activation) of caspase-14 in Mcl-1 shRNA cultures. The addition of z-VAD did not significantly alter the expression of any differentiation markers in either control or Mcl-1 shRNA cultures, indicating that the increase in caspase-dependent apoptosis was not responsible for the decreased differentiation marker expression in Mcl-1 shRNA cultures.
DISCUSSION
The coordinated regulation of epidermal KC proliferation, differentiation, and apoptosis is vital to the function of skin under physiological conditions, as well as in response to physical and genotoxic stresses (Raj et al., 2006) . In this study, we have identified Mcl-1 as a critical antiapoptotic protein for KCs that also is involved in the regulation of the KC differentiation program. We were specifically interested in the epidermal function of Mcl-1 due to its involvement in the UV radiation apoptotic pathway, and its critical role in early embryonic development (Rinkenberger et al., 2000; Nijhawan et al., 2003; Sitailo et al., 2006) . Our studies (Figure 1 ) localized Mcl-1 within the human epidermis with higher expression in the spinous and especially granular layers, consistent with previous reports (Krajewski et al., 1995; Thomkova et al., 1999) . Although the increased expression of Mcl-1 in the more differentiated layers is suggestive of a role for Mcl-1 in differentiation, it may also simply reflect increased protection from apoptosis as KCs proceed through their terminal differentiation program. We tested this possibility by downregulating Mcl-1 in human KC induced to terminally differentiate in organotypic raft cultures.
Knockdown of Mcl-1 in organotypic cultures of human KC induced spontaneous apoptosis in the upper spinous and granular layers (Figures 3 and 4 are embryonic lethal due to extensive hematopoietic and neuronal cell death, although these mice survive much longer than Mcl-1-deficient mice (E13 vs E3.5, respectively) (Motoyama et al., 1995; Rinkenberger et al., 2000) . Mice with targeted disruption of Bcl-x in their epidermis were viable and did not show alteration in skin development, but spontaneous apoptotic epidermal KCs were detected (Umeda et al., 2003) . Thus, Bcl-x is also a nonredundant survival protein for epidermal KCs. Bax and Bcl-2 null mice do not exhibit any increased spontaneous epidermal apoptosis, although they expressed elevated levels of loricrin and K1 (Cho et al., 2001) . Pharmacological inhibition of PI3K induced spontaneous apoptosis and reduced differentiation marker expression in cultured KCs induced to differentiate with extracellular calcium, implicating that the PI3K-AKT pathway in control between differentiation and apoptosis (Calautti et al., 2005) . We previously reported that knockdown of Mcl-1 in monolayer culture induced a much smaller increase in spontaneous KC apoptosis than what we observed here in organotypic culture, possibly due to increased apoptotic signals present during terminal differentiation . Inhibition of apoptosis with the caspase inhibitor z-VAD partially rescued the reduced cornification observed in the Mcl-1 shRNA cultures, indicating that apoptosis was an alternative cell fate to cornification (Figures 3 and 5) . In contrast, we clearly demonstrated that expression of both early (K1, K10) and late (involucrin, loricrin, filaggrin) differentiation markers was not altered by inhibition of caspases with z-VAD (Figures 7 and 8) . The incomplete rescue of cornification by z-VAD is likely because of the requirement for proper differentiation marker expression to produce mature, detergent-resistant cornified envelopes. Thus, the effects of Mcl-1 downregulation on differentiation marker expression are independent of apoptosis and constitute a previously unreported function for Mcl-1. Other studies found that general caspase inhibition either reduced the loss of nuclei during cornification (Weil et al., www.jidonline.org 1355 1999) or inhibited expression of differentiation markers involucrin and loricrin (Chaturvedi et al., 2006) , leading to the conclusion that differentiation and cornification in part require apoptotic caspase activation. Several important differences exist between the experimental system used in these studies and our current study. Organotypic culture systems lacking fibroblasts in the dermal layer appear to be primed for apoptosis as significant apoptotic caspase activation is detected after lifting to the air-liquid interface (Weil et al., 1999; Chaturvedi et al., 2006) . Other in vitro differentiation model systems support our conclusion that differentiation and apoptosis are alternative cell fates (Mitra et al., 1997; Gandarillas et al., 1999; Lippens et al., 2000) .
Caspase-14 is a unique member of the caspase family of cysteine proteases due to its selective expression and proteolytic processing in terminally differentiating KCs (Eckhart et al., 2000; Lippens et al., 2000; Chien et al., 2002) . The proteolytic activation of caspase-14 is mediated by an uncharacterized protease that generates p20 large and p10 small subunits. Processed and activated caspase-14 has a substrate specificity similar to other caspases, W/Y-X-X-D, although it is not activated by conventional apoptotic stimuli (Hu et al., 1998; Chien et al., 2002; Park et al., 2006) . Caspase-14 null mice have defective epidermal barrier function and altered profilaggrin processing, indicating a role for caspase-14 in epidermal terminal differentiation (Denecker et al., 2007) . Immunofluorescence staining for caspase-14 in control organotypic cultures showed granular and upper spinous layer expression (Figure 6 ), consistent with other reports examining caspase-14 in vivo (Eckhart et al., 2000; Kuechle et al., 2001) . A significant proportion (B50%) of the caspase-14 we detected from our organotypic cultures was processed and presumably activated (Figures 6 and 8) .
We did not detect processing of caspase-14 in monolayer culture of human KCs, even after 2 days at confluence in high-calcium media or in KC induced to differentiate in suspension culture (data not shown). Thus, caspase-14 expression and proteolytic processing are tightly linked to the KC differentiation program and can be considered a bona fide differentiation marker. Caspase-14 expression in Mcl-1 shRNA organotypic cultures was reduced, expressed prematurely in the lower spinous layers, and was not proteolytically processed/activated (Figures 6 and 8 ). Caspase inhibition with z-VAD had no effect on the expression or processing of caspase-14, indicating that the differentiation signal(s) inducing caspase-14 activation are independent from the canonical caspase-dependent apoptotic pathway. The inability of z-VAD to prevent processing of caspase-14 is consistent with the non-caspase cleavage sites identified for caspase-14, although the enzymatic activity of processes caspase-14 would be expected to be inhibited by z-VAD (Chien et al., 2002) .
Overall, our studies demonstrate that Mcl-1 is required for proper KC differentiation, although the mechanism(s) of regulation of KC differentiation by Mcl-1 is currently unclear. The vast majority of functional studies on Mcl-1 have focused on its antiapoptotic function by sequestering proapoptotic Bcl-2 family members to prevent permeability of the mitochondrial outer membrane GomezBougie et al., 2005; Willis et al., 2005; Clohessy et al., 2006; Qin et al., 2006) . However, other Mcl-1-binding proteins have been identified that may be involved in KC differentiation control. Fujise and colleagues identified the calciumbinding protein fortilin/TCTP as being bound and stabilized by Mcl-1 (Haghighat and Ruben, 1992; Zhang et al., 2002; Graidist et al., 2007) . Given the important role of calcium in KC differentiation, it is conceivable that the stabilization of fortilin by Mcl-1 may help regulate the calcium scavenging function of fortilin (Hennings et al., 1980; Li et al., 1995) . Mcl-1 has also been shown to bind proliferating cell nuclear antigen, and this binding was partially required for Mcl-1 to inhibit S-phase progression (Fujise et al., 2000) . A proteolytic fragment of Mcl-1 also binds to Cdk1 and inhibits its kinase activity, providing another potential mechanism for Mcl-1 to inhibit proliferation (Jamil et al., 2005) . Thus, downregulation of Mcl-1 may impede KC differentiation by altering cell-cycle progression to favor cell proliferation over differentiation. Consistent with this, we found an increase in KCs in the S phase of the cell cycle when Mcl-1 was downregulated (data not shown).
MATERIALS AND METHODS
Antibodies and chemicals
Mcl-1 was detected using an antibody against an internal part of Mcl-1 protein (sc-819; Santa Cruz Biotechnology Inc., Santa Cruz, CA) that can detect both the Mcl-1L 42-40 kDa and Mcl-1S 32 kDa isoforms. This antibody was used for western blotting at 1:1000 and for tissue immunostaining at 1:100. Total caspase-3 was detected by western blot (sc-2727; Santa Cruz Biotechnology Inc.), and active caspase-3 detected in tissue sections by immunofluorescence (AF835; R&D Systems, Minneapolis, MN). The following differentiation marker antibodies were used: loricrin (PRB-145P; Covance Research Products Inc., Berkeley, CA) at 1:1,000 for Western blotting and 1:250 for immunofluorescence; filaggrin (PRB-417P; Covance Research Products Inc.) at 1:1,000 for western blotting and 1:250 for immunofluorescence; caspase-14 (sc-5628; Santa Cruz Biotechnology Inc.) at 1:500 for western blotting and 1:100 for immunofluorescence; involucrin (sc-21748; Santa Cruz Biotechnology Inc.) at 1:500 for western blotting. The general caspase inhibitor z-VAD-FMK (51-69361U; BD Biosciences Pharmingen, San Jose, CA) was prepared as 10 mM stock solution in DMSO, aliquoted and stored at À20 1C.
Cell culture
Primary human KCs were isolated from neonatal foreskin tissue as described previously, and approved by the Loyola University Medical Center Institutional Review Board (Denning et al., 1998) . KCs were maintained in Media 154CF with human KC growth supplement and 0.07 mM Ca 2 þ (Cascade Biologics, Portland, OR).
For suspension-induced differentiation, KCs were trypsinized, suspended in a small volume (50-100 ml) of Dulbecco's Modified Eagle's Medium and 10% fetal bovine serum, and mixed into the same medium containing 1.75% methylcellulose with or without 10 mM z-VAD. After 24 hours, the cells were washed twice in phosphate-buffered saline and analyzed for western blotting or cross-linked protein formation.
Organotypic cultures
Organotypic raft cultures were generated based on the protocol described by Meyers et al. (1994) . Control shRNA or Mcl-1 shRNAinfected KCs were initially selected in the presence of 1 mg ml À1 puromycin in subconfluent monolayer cultures. In some experiments, KCs were transfected with SMARTpool siRNAs targeting Mcl-1 (MV-004501-04; Dharmacon Inc., Lafayette, CO). Collagen (type I rat tail, 3.79 mg ml À1 ; BD Biosciences, Bedford, MA) plugs with 10 5 J2-3T3 fibroblasts per ml were made in 12-well cell culture inserts (1.0 mm pore size, PET track-etched membrane; Becton Dickinson, Franklin Lakes, NJ), and incubated for 1 day. A total of 2 Â 10 6 control shRNA or Mcl-1 shRNA KCs were plated on top of each plug in E-media supplemented with 5 ng ml À1 of epidermal growth factor.
After 2 days, KC differentiation was initiated by lifting organotypic cultures to the air-liquid interface. E media (1 ml, ±10 mM z-VAD) were added to the bottom of each wells and changed daily for the next 5-6 days. Organotypic cultures were then fixed in neutral buffered formalin and processed for histology, or the epidermis removed for either protein or cornified envelope analysis.
shRNA cloning and retrovirus production
Retroviruses encoding siRNA hairpins were constructed using pSUPER.retro.puro vector system (OligoEngine, Seattle, WA) as described previously . Briefly, double-stranded oligonucleotides targeting Mcl-1 or no human gene (control) were cloned into pSUPER.retro.puro, and retroviruses generated by www.jidonline.org 1357
transfecting Phoenix-Ampho cells (ATCC, Manassas, VA). Packing cells were selected with puromycin (1 mg ml À1 ), and the viruses were used to infect normal human KC, which were also selected with puromycin.
Western blots
KCs were washed with phosphate-buffered saline, scrapped in lysis buffer: 20 mM Tris-HCl, pH 7.5, 5 mM EDTA, 1% Triton X-100, 1 Â complete protease inhibitor cocktail, 1 mM sodium fluoride, 1 mM sodium orthovanadate, 10 mM b-glycerophosphate. For epidermal extracts, foreskins were incubated in 60 1C water for 45 seconds, cooled in ice water, and the epidermis removed with a razor blade and placed into lysis buffer. Protein extracts were briefly sonicated, centrifuged at 10,000 g for 5 min, and protein concentration was estimated by Bradford assay. Usually 30 mg per well was loaded on 8.5 or 12.5% SDS-PAGE gel. For western blot analysis of filaggrin, involucrin, and loricrin, 0.5% SDS was included in the lysis buffer and the extract was heated for 5 min at 95 1C to increase protein extraction. Quantitation of band intensities was done using an Odyssey Infrared Imaging System.
Staining of tissues
For immunofluorescence staining paraffin sections of rafts on glass slides were deparaffinized by soaking in xylene 5 min, then another xylene 5 min, dipping up and down 10 Â in 100% ethanol, 10 Â in 95% ethanol and 10 Â in ddH 2 O and rinsed once in Difco FA Buffer (Becton, Dickinson and Co., Sparks, MD). For antigen retrieval of formalin-fixed, paraffin-embedded samples, slides were placed in a rack for heating in the pressure cooker in 10 mM citrate buffer (pH 6.0) for 10 minutes, and then cooled for 20 min with lid off. Slides were removed from cooker and equilibrated in formaldehyde buffer for 10 minutes. 50 ml primary antibody was used per slide staining in moisture chamber for 1 h at room temperature. Then slides washed for 5 min in FA Buffer and stained with AlexaFluor 488 (anti-mouse) or AlexaFluor 568 (anti-rabbit) secondary antibodies at 1:400 (A11001 and A11036; Molecular Probes, Eugene, OR) for 1 h at room temperature. After washing 5 min in formaldehyde buffer slides were mounted with coverslips on gelvatol (polyvinyl alcohol, 30,000-70,000 MW; Sigma, St Louis, MO) plus 1,4-diazabicyclo-[2.2.2]octane (Sigma). Immunoperoxidase staining was performed using peroxidase-labeled secondary antibody, followed by color detection with the Vectastain ABC kit (Vector Laboratories, Burlingame, CA) and diaminobenzidine as a substrate. Sections were counterstained with hematoxylin for 3 min and mounted in Aqua-Mount (catalog no. 13800; Lerner Lab, Pittsburgh, PA). For TUNEL staining, 8 mm sections were cut from control shRNA and Mcl-1 shRNA organotypic culture paraffin blocks. Peroxidase staining of sections was performed with ApopTag Peroxidase In Situ Detection Kit as described by the manufacturer (S7100; Chemicon International Inc., Temecula, CA). For quantitation, treatment groups were concealed and TUNEL-positive cells counted in three randomly selected fields ( Â 20 objective). Photographs were taken with Olympus AX80 fluorescence microscope equipped with a Retiga 4000R 4.2 Mpixel monochrome camera.
Quantitation of cross-linked protein and cornified envelopes
Cornified envelopes resistant to heating in SDS/dithiothreitol, DTT, were quantified by a membrane-binding assay or by counting cornified envelopes in a hematocytometer. Total cells were collected from suspension culture or trypsinized from raft epidermis and counted. Cornified envelopes were prepared by heating cells at 90 1C for 10 min in 2% SDS, 20 mM DTT, and resistant cornified cells were counted directly under the hemacytometer. For cross-linked protein measurements, the envelopes were washed 2 Â in SDS/DTT buffer by spinning at 11,000 g to remove soluble protein before applying to a RC60 membrane (Schleicher & Schuell; pore size 1.0 mm; Keene, NH) on slot blot vacuum manifold (Hough-Monroe and Milstone, 1991) . A total of 10 5 cells in 50 ml were applied per slot. Wells were washed 3 Â with SDS/DTT buffer and the membrane was air-dried, submerged in 7.5% TCA at 80 1C for 30 min. The membrane was stained with constant rocking in 1% Coomasie Blue G250 in 7% acetic acid for 15 min at 50 1C. After washing with 7% acetic acid at 50 1C for 5 min, the stained spots were cut out and placed in tube, and the dye eluted in 400 ml of 66% methanol, 1% ammonium hydroxide. Absorbance was read at 600 nm to quantify the cross-linked protein. All statistics were performed using a two-tailed Student's t-test.
